Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03436433Phase 2Terminated
A Phase 2 trial of lacosamide, levetiracetam in epilepsy, sponsored by Duke University. Started Jan 2019; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03436433.